Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTXYK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,158
Award facts
- Contract value 100% obligated
- $17,158.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $17,158.05. This is a firm fixed-price delivery order with no set-aside designation, utilizing a competitive award process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds extensive contract awards with the Defense Logistics Agency covering a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the company's role in supplying contemporary pharmaceutical therapies to support Defense Health Agency operations and other federal healthcare systems. As a prime contractor under the DLA's pharmaceutical support infrastructure, AmerisourceBergen demonstrates capability to fulfill federal medical supply requirements through competitive procurement channels and maintains the operational capacity to distribute pharmaceutical products globally to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FTXYK?
SPE2DB25FTXYK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FTXYK worth?
The government has obligated $17,158 on SPE2DB25FTXYK.
Is contract SPE2DB25FTXYK an order under another contract?
Yes. SPE2DB25FTXYK is a delivery order under SPE2DB25D7068, an indefinite delivery contract.
Was contract SPE2DB25FTXYK competed?
The extent of competition for SPE2DB25FTXYK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award